The remaining 468 patients (HLA-A n = 414, HLA-B n = 468) constitute the available study population, comprising 186 patients with HIV infection, 120 patients with chronic hepatitis C, and 162 patients with HIV/HCV co-infection. Here, HLA-A is linked to coinfection.